UCARS 2025 Thursday - Session 3: Myocardial recovery: evidence and implementation

Session 3: Myocardial recovery: evidence and implementation (Non-CME)
Chairs: James Long, MD, Integris Health; Stephen McKellar, MD, Intermountain Health

1. How is progression of disease/HFrEF affecting the cardiac recoverability? Is this the same for all HFrEF therapies? Liviu Klein, UCSF
2. How to (a) individualize the probability of recovery and (b) guide recommendations for ‘direct transplant’ vs ‘VAD as bridge’. Maya Guglin, MD, Rutgers Robert Wood Johnson
3. Durability of recovery after VAD weaning: results from VAD WEAN Recovery Registry. Benjamin Sun, MD, Minneapolis Heart Institute
4. Upgraded recommendations for recovery in the ISHLT guidelines. Michael Tong, MD, Cleveland Clinic
5. UNOS and INTERMACS evidence of under diagnosis and underutilization of LVAD-mediated recovery. Anelechi Anyanwu, MD, Mount Sinai
6. Reasons for under diagnosis and underutilization and ways to address them. Palak Shah, MD, INOVA

Discussants Panel: Snehal Patel, MD, Montefiore; Amanda Vest, MD, Cleveland Clinic; Kartik Sundareswaran, PhD, Abbott; Abdallah Kfoury, MD, Intermountain Health; Stavros Drakos, MD/PhD, U of U